Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|January 13, 2021
[COVID-19: Would compulsory vaccination be legally possible?]Fabian-Simon Frielitz, Isabel Viola Wagner, Denis Martin Schewe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancersDenis Martin Schewe, Tobias Biller, Gabriele Maurer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancersDenis Martin Schewe, Joerg H Leupold, Douglas D Boyd, et al.Journal of Clinical Medicine|July 2, 2021
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In VivoDorothee Winterberg, Lennart Lenk, Maren Oßwald, et al.Antibodies (Basel, Switzerland)|November 20, 2020
Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-EngineeringSophia Roßkopf, Klara Marie Eichholz, Dorothee Winterberg, et al.Frontiers in Immunology|September 19, 2022
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibodyCarina Lynn Gehlert, Pegah Rahmati, Ammelie Svea Boje, et al.Leukemia|November 21, 2022
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)Sophie Steinhäuser, Patricia Silva, Lennart Lenk, et al.Pageof 1